Price to sales forward of AptarGroup, Inc. – NYSE:ATR
This article provides financial data for AptarGroup, Inc. (NYSE: ATR), focusing on its forward price-to-sales ratio. It indicates that the company's market is currently closed with no trades recorded. The content is primarily a data placeholder within a financial platform, showing the period, value, and change for this specific metric.
Y Intercept Hong Kong Ltd Acquires 13,984 Shares of AptarGroup, Inc. $ATR
Y Intercept Hong Kong Ltd recently increased its stake in AptarGroup, Inc. by 37.7%, acquiring an additional 13,984 shares to bring its total holdings to 51,065 shares valued at approximately $6.44 million. This move follows AptarGroup's strong first-quarter performance, which saw better-than-expected EPS of $1.19 and a 10.8% increase in revenue. Analysts currently maintain a "Moderate Buy" rating for AptarGroup with a consensus target price of $173.25.
AptarGroup, Inc. $ATR Shares Sold by SG Americas Securities LLC
SG Americas Securities LLC reduced its stake in AptarGroup (NYSE:ATR) by 54.5% in the first quarter, selling 12,987 shares and retaining 10,861 shares valued at $1.37 million. Despite this, AptarGroup reported strong Q1 earnings of $1.19 per share, beating estimates, and guided Q2 2026 EPS to $1.32-$1.40. The company also pays a quarterly dividend of $0.48 per share and is rated a Moderate Buy by analysts with an average price target of $173.25.
ATR - Aptargroup Inc Latest SEC Filings
This article provides the latest SEC filings and a comprehensive financial overview for Aptargroup Inc. (ATR), including key financial metrics, stock performance data, and insider/institutional ownership percentages. It details current trading information, dividend statistics, and various valuation ratios.
AptarGroup, Inc. $ATR is Boston Trust Walden Corp's 7th Largest Position
Boston Trust Walden Corp slightly reduced its stake in AptarGroup (NYSE:ATR) by 4.6% in the first quarter, but it remains their 7th largest holding, valued at approximately $170.1 million. Despite the sell-off, AptarGroup reported strong Q1 results, exceeding earnings and revenue estimates, and announced a quarterly dividend of $0.48 per share. Insider sales by Shiela Vinczeller and Irene Elizabeth Hudson were also noted.
Q2 Earnings Estimate for AptarGroup Issued By Zacks Research
Zacks Research has slightly lowered its Q2 2028 EPS estimate for AptarGroup to $1.64 from $1.65, while maintaining a "Hold" rating on the stock. AptarGroup recently surpassed expectations in its latest quarter, reporting an EPS of $1.19 and revenue of $982.87 million, a 10.8% increase year over year. The company also declared a quarterly dividend of $0.48 per share, representing an annualized yield of about 1.5%.
FY2026 EPS Estimates for AptarGroup Lifted by Zacks Research
Zacks Research has increased its FY2026 EPS estimate for AptarGroup to $5.40 and projected FY2027 EPS at $5.84, while maintaining a "Hold" rating. This update follows AptarGroup's strong Q1 2026 earnings, which surpassed expectations with an EPS of $1.19 and revenue of $982.87 million, and the company has also provided optimistic guidance for Q2 2026. Analyst sentiment remains largely positive, holding a "Moderate Buy" consensus and a price target of $173.25.
Janney Montgomery Scott LLC Decreases Position in AptarGroup, Inc. $ATR
Janney Montgomery Scott LLC reduced its stake in AptarGroup, Inc. by 5.4% during the first quarter, selling 10,702 shares. Despite this, analysts maintain a "Moderate Buy" rating with an average price target of $173.25, and Wells Fargo recently increased its price target to $145. AptarGroup reported strong quarterly results, with EPS of $1.19 and revenue up 10.8% year-over-year, and declared a quarterly dividend of $0.48 per share.
18,700 Shares in AptarGroup, Inc. $ATR Acquired by Louisiana State Employees Retirement System
The Louisiana State Employees Retirement System recently acquired 18,700 shares of AptarGroup, Inc. (NYSE:ATR) worth approximately $2.36 million during the first quarter. This comes as AptarGroup reported strong quarterly results, exceeding EPS and revenue estimates, and announced a quarterly dividend. Institutional ownership in the company remains high at 88.52%, though some insiders have sold shares.
AptarGroup, Inc. (ATR) Investor Outlook: Exploring a 27% Potential Upside in the Healthcare Sector
AptarGroup, Inc. (ATR), a prominent healthcare sector company with an $8.04 billion market cap, shows potential for a 27% upside, according to analysts. The company, known for drug delivery and consumer product dispensing solutions, exhibits strong revenue growth of 10.80% year-over-year and a healthy free cash flow of $253 million. With positive analyst ratings, a reasonable forward P/E of 20.08, and a stable stock performance near the midpoint of its 52-week range, AptarGroup presents a compelling investment case in the healthcare sector.
Q4 EPS Estimates for AptarGroup Increased by Zacks Research
Zacks Research has slightly increased its Q4 2026 EPS estimate for AptarGroup to $1.47 from $1.46, maintaining a "Hold" rating. Other analysts show mixed views, with a consensus of "Moderate Buy" and an average target price of $173.25. AptarGroup recently surpassed earnings expectations for its last quarter and provided Q2 2026 guidance.
AptarGroup, Inc. Actuals & Estimates (NYSE:ATR)
This article provides an overview of AptarGroup, Inc. (NYSE:ATR) stock performance, financial actuals and estimates, and various key metrics. It includes details on the current stock price, historical highs and lows, market capitalization, upcoming earnings reports, and dividend information. The report also addresses frequently asked questions about ATR stock for potential investors.
AptarGroup, Inc. Actuals & Estimates (TRADEGATE:AGT)
This article provides an overview of AptarGroup, Inc. (TRADEGATE:AGT) stock, including financial actuals, analyst estimates, and key statistics. It covers information such as stock ticker, price forecasts, historical price movements, earnings reports, revenue, net income, dividends, employee count, and EBITDA. The content acts as a guide for potential investors to research AGT's financial performance and analyst opinions.
The Glide Pharma Pump from AptarGroup Inc. - discreet insulin delivery for daily use
AptarGroup Inc. has developed the Glide Pharma Pump, a discreet, prefilled, multi-dose insulin delivery system designed for pharma partners and patients. It offers a compact, palm-sized format with tactile feedback for ease of use, particularly for those with reduced dexterity. While targeting drug makers rather than consumers, this system contributes to AptarGroup's injectable drug delivery portfolio and aims to streamline pharmaceutical workflows and improve patient experience.
ATR Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for AptarGroup, Inc. (ATR) stock for 2027, based on analyst opinions. It details current stock performance, historical highs and lows, financial data like revenue and earnings, and dividend information. The report also addresses frequently asked questions about ATR's stock, including market capitalization, volatility, and upcoming earnings dates.
Aptargroup Inc (ATR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
Aptargroup Inc (ATR) has a current price momentum score of 8.95 and is trading between resistance at $124.72 and support at $113.12, suggesting suitability for range-bound swing trading. Technical indicators show a mixed signal with 1 buy, 4 neutral, and 2 sell ratings, while moving averages present 4 buy and 2 sell signals. Overall, the technical analysis based on moving averages and other indicators suggests a "Sell" signal for Aptargroup Inc.
River Road Asset Management LLC Purchases Shares of 917,670 AptarGroup, Inc. $ATR
River Road Asset Management LLC has acquired a new stake of 917,670 shares in AptarGroup, Inc. (NYSE:ATR) during the fourth quarter, valued at approximately $111.9 million. This significant investment makes AptarGroup a notable position in River Road's portfolio, highlighting continued institutional interest in the company. AptarGroup has also shown positive financial performance, with better-than-expected earnings and institutional ownership remaining high.
AptarGroup (ATR) Stock Could Be 25.5% Undervalued on Its Drug Delivery Growth Narrative
AptarGroup (ATR) stock is gaining investor interest, showing a 6% increase in the past month despite an 18.47% decline over the last year. While an intrinsic value estimate suggests the stock is 25.5% undervalued at $120.32 compared to a fair value of $161.43, primarily due to its expanding drug delivery systems, its P/E ratio of 19.9x is higher than the industry average, indicating the market may already be pricing in a premium. The company faces both growth opportunities in healthcare and challenges from legal costs and uncertain demand for certain delivery systems.
Aptar Releases 2025 Corporate Sustainability Report
AptarGroup, Inc. released its 2025 Corporate Sustainability Report, "Progress in Motion," detailing its advancements in global sustainability. The report highlights progress across three pillars: Care, Collaboration, and Circularity, and notes that 98% of Aptar’s electricity was sourced from renewable sources by the end of 2025. It also mentions a completed CSRD-aligned double materiality assessment and ongoing innovation towards more sustainable products.
Aptar Releases 2025 Corporate Sustainability Report
Aptar (NYSE: ATR) has released its 2025 Corporate Sustainability Report, "Progress in Motion," detailing the company's global sustainability strategy focused on Care, Collaboration, and Circularity. The report highlights significant achievements in 2025, including sourcing 98% of its electricity from renewable sources and completing a CSRD-aligned double materiality assessment. Aptar continues to prioritize employee and community support, along with innovation for more sustainable products.
Aptar Releases 2025 Corporate Sustainability Report
AptarGroup, Inc. released its 2025 Corporate Sustainability Report, "Progress in Motion," detailing achievements in its global sustainability strategy across three pillars: Care, Collaboration, and Circularity. Key highlights include sourcing 98% of electricity from renewable sources by year-end 2025 and completing a CSRD-aligned double materiality assessment. The report emphasizes Aptar's commitment to continuous improvement in environmental impact, fostering partnerships for sustainable outcomes, and driving system-scale change to address climate and waste challenges.
Aristotle Capital Boston LLC Grows Stake in AptarGroup, Inc. $ATR
Aristotle Capital Boston LLC significantly increased its stake in AptarGroup, Inc. (NYSE:ATR) by 394.1% in the fourth quarter, now owning 149,636 shares valued at $18.25 million. Other institutional investors also adjusted their holdings, and the company recently reported strong quarterly earnings, beating analyst estimates. AptarGroup also declared a quarterly dividend of $0.48, reflecting a 1.6% yield.
Aptargroup Inc (ATR) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides historical dividend and stock split information for Aptargroup Inc (ATR), detailing dividend payout dates, record dates, ex-dividend dates, and amounts. It indicates that a total of $415.71 million has been distributed in dividends over the past five years and notes the absence of historical stock split data. The current stock price and key financial metrics like market cap and P/E ratio are also included.
Aptargroup Inc (ATR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides an overview of Aptargroup Inc's (ATR) revenue breakdown by region for the fiscal year 2025. It shows that the company generated $1.07 billion from the United States, representing 28.37% of its total revenue, with other European and foreign countries also contributing significantly. The report also notes that relevant data for business segments for FY2025 has not yet been disclosed by the company.
Aptargroup Inc (ATR) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Aptargroup Inc (ATR), listing its major shareholders and institutional holdings. Key shareholders include BlackRock Institutional Trust Company, N.A., State Farm Insurance Companies, and Vanguard Portfolio Management, LLC. The report also breaks down shareholder types and provides a quarterly view of institutional shareholding changes.
London Co. of Virginia Sells 62,706 Shares of AptarGroup, Inc. $ATR
London Co. of Virginia reduced its stake in AptarGroup (NYSE:ATR) by 6.4% in the fourth quarter, selling over 62,000 shares, though it still holds a significant position valued at $111 million. This comes as AptarGroup exceeded earnings expectations for the latest quarter and analysts generally maintain a "Moderate Buy" rating for the company. Insider activity also shows some share sales by executives.
APTARGROUP (NYSE: ATR) CAO receives 2,664-share stock grant in Form 4
APTARGROUP, INC. (NYSE: ATR) Chief Accounting Officer Aditya Gandhi was granted 2,664 shares of common stock as compensation, according to a recent Form 4 filing. This transaction, coded as a "Grant/Award," established his direct holdings at 2,664 shares with a stated price of $0.0000 per share. The filing clarifies that this was a compensation-related acquisition, not an open-market purchase or sale.
AptarGroup, Inc. (NYSE:ATR) Receives Consensus Recommendation of "Moderate Buy" from Analysts
AptarGroup, Inc. (NYSE:ATR) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $173.25. The company recently surpassed quarterly earnings and revenue estimates and announced Q2 2026 EPS guidance. While institutional investors largely own the stock, some insiders have recently sold shares.
Nitrosamine-mitigation Packaging Technology From: AptarGroup, Inc.
Aptar Active Material Science has achieved a significant intellectual property milestone with the USPTO allowance of its N-Sorb technology, a packaging-delivered approach to mitigate nitrosamine risks in pharmaceuticals. This technology combines material science innovation with proven performance on drug products, applying across various packaging configurations without altering formulations or manufacturing processes. The patent covers both the material composition and validated nitrosamine reduction, potentially supporting FDA Orange Book listing and offering enhanced regulatory and commercial protections for pharmaceutical partners.
Aurora Investment Counsel Invests $1.31 Million in AptarGroup, Inc. $ATR
Aurora Investment Counsel has initiated a new position in AptarGroup, Inc. (NYSE:ATR) during the fourth quarter, acquiring 10,743 shares valued at approximately $1.31 million. AptarGroup recently surpassed quarterly earnings expectations, reporting an EPS of $1.19 against an estimated $1.15 and revenue of $982.87 million, an increase of 10.8% year-over-year. The company also declared a quarterly dividend of $0.48 per share and holds a "Moderate Buy" consensus rating with an average analyst price target of $173.25.
AptarGroup, Inc. $ATR Shares Acquired by Victory Capital Management Inc.
Victory Capital Management Inc. increased its stake in AptarGroup, Inc. (NYSE:ATR) by 4.0% in the fourth quarter, bringing its total holdings to 2.29 million shares. Despite some mixed analyst sentiment, the company reported strong Q1 results, beating EPS and revenue estimates, and provided positive Q2 guidance. Institutional ownership remains high at 88.52%, though certain insiders have recently sold shares.
Aptar Active Material Science secures USPTO patent for packaging-delivered nitrosamine mitigation technology
Aptar Active Material Science has secured a USPTO patent for its N-Sorb SM technology, which mitigates nitrosamine impurities in pharmaceutical packaging across various formats. This innovation combines material science with API-level nitrosamine reduction, offering pharmaceutical partners a new strategy for risk mitigation and potential FDA Orange Book listing. The technology was previously accepted into the FDA’s Emerging Technology Program, highlighting its significance for product integrity and patient safety.
Aptargroup segment president Marc Prieur sells $577,894 in shares
Aptargroup segment president Marc Prieur sold 5,000 shares of APTARGROUP, INC. (NASDAQ:ATR) stock for a total of $577,894 on June 9, 2026. The sales occurred in two transactions at prices ranging from $114.9900 to $116.1219 per share, leaving Prieur with 19,323 shares. This follows strong Q1 2026 financial results for AptarGroup and a raised price target from BofA Securities.
Aptar cites rising resin, transportation costs as inflation returns
AptarGroup is experiencing renewed inflation due to increasing resin and transportation costs, which are particularly impacting its closures business. The article highlights these rising expenses as a challenge for the company, indicating a return of inflationary pressures.
Aptar Active Material Science Secures USPTO Allowance for N-Sorb℠ Technology, Establishing First-of-Its-Kind Packaging-Delivered Approach to Nitrosamine Risk Mitigation
Aptar Active Material Science has secured a U.S. patent allowance for its N-Sorb℠ technology, which offers a unique packaging-delivered solution for mitigating nitrosamine impurities in pharmaceutical products. This technology integrates advanced material science with demonstrated performance on drug products, applying to various packaging forms like blisters and bottles without altering existing formulations or manufacturing processes. The patent covers the proprietary material composition and its ability to reduce nitrosamines across multiple active pharmaceutical ingredients, potentially enhancing regulatory and commercial protection strategies for pharmaceutical partners.
Aptargroup Insider Sold Shares Worth $577,895, According to a Recent SEC Filing
An insider at Aptargroup recently sold shares valued at $577,895, as disclosed in a new SEC filing. This transaction follows other insider share sales reported in May and June. AptarGroup, Inc. designs and manufactures drug and consumer product dosing, dispensing, and protection technologies across various end markets.
[Form 4] APTARGROUP, INC. Insider Trading Activity
AptarGroup Segment President Marc Prieur reported selling 5,000 shares of company common stock in two open-market transactions on June 9, 2026. The sales were made at weighted average prices between $115 and $116 per share, totaling approximately $577,895. Following these transactions, Prieur directly beneficially owns 19,770 shares of AptarGroup common stock.
Bank of New York Mellon Corp Has $65.43 Million Stake in AptarGroup, Inc. $ATR
Bank of New York Mellon Corp decreased its stake in AptarGroup, Inc. by 7.1% during the fourth quarter, yet still holds 536,513 shares valued at approximately $65.4 million. AptarGroup recently reported strong Q1 results, surpassing EPS estimates and achieving a 10.8% year-over-year revenue increase. The company also announced a quarterly dividend and issued optimistic guidance for Q2 2026, leading analysts to rate the stock a Moderate Buy with a target price of $173.25.
AptarGroup Inc stock (US0383361039): focus on packaging innovation after latest quarterly results
AptarGroup Inc, a global specialist in dispensing and packaging solutions for consumer and healthcare markets, remains a focus for investors following its latest quarterly results. The company emphasizes innovation in drug delivery and consumer packaging, operational efficiency, and disciplined capital allocation. Its position at the intersection of packaging, materials engineering, and regulated healthcare markets allows it to navigate diverse market cycles and competitive landscapes, offering investors exposure to both consumer and healthcare sectors.
[144] APTARGROUP, INC. SEC Filing
This SEC filing (Form 144) for APTARGROUP, INC. (ATR) indicates a proposed sale of 5,000 common shares by an unnamed person for whose account the securities are to be sold. The shares, acquired through RSUs and PSUs on March 14, 2022, have an aggregate market value of $565,000.00 and are intended to be sold on the NYSE around June 10, 2026, via UBS Switzerland AG.
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference - Slideshow
AptarGroup, Inc. (ATR) presented a slideshow at the 16th Annual Wells Fargo Industrials & Materials Conference. The slide deck was published in conjunction with this event and the content was provided by SA Transcripts.
AptarGroup (NYSE: ATR) CAO Aditya Gandhi files initial Form 3
AptarGroup's Chief Accounting Officer, Aditya Gandhi, has filed an initial Form 3 with the SEC, establishing him as a reporting insider. This filing indicates no beneficial ownership of securities or transactions at the time it was submitted. The Form 3 serves to notify regulatory bodies of his new status, requiring future disclosures of his holdings and trading activities.
Aptargroup CHRO Shiela Vinczeller sells $400,341 in company stock
Aptargroup's CHRO, Shiela Vinczeller, sold 3,555 shares of company stock for a total of $400,341 on June 4, 2026. This transaction leaves her with 27,078 shares directly held. The sale occurred as ATR stock is down 25% over the past year but near its 52-week low.
Nuance Investments LLC Buys 145,233 Shares of AptarGroup, Inc. $ATR
Nuance Investments LLC significantly increased its stake in AptarGroup, Inc. (NYSE:ATR) by 141.1% in the fourth quarter, purchasing an additional 145,233 shares and raising its total holding to 248,193 shares valued at approximately $30.27 million. AptarGroup recently surpassed quarterly earnings expectations with an EPS of $1.19 and revenue of $982.87 million, while also declaring a quarterly dividend of $0.48 per share. The company currently holds a "Moderate Buy" consensus rating from analysts, with an average target price of $173.25.
Norges Bank Takes Position in AptarGroup, Inc. $ATR
Norges Bank has initiated a new position in AptarGroup, Inc. (NYSE:ATR) during the fourth quarter, acquiring 746,940 shares valued at approximately $91.1 million, which constitutes 1.14% of the company. This move follows AptarGroup's better-than-expected quarterly results and increased Q2 2026 guidance. Analysts currently rate the stock as a "Moderate Buy" with a consensus target price of $173.25, while institutional investors hold 88.52% of the company's stock.
EULAV Asset Management Decreases Stock Holdings in AptarGroup, Inc. $ATR
EULAV Asset Management significantly reduced its stake in AptarGroup, Inc. by 77.9% in the fourth quarter, selling 244,292 shares and ending with 69,332 shares valued at $8.46 million. This follows other institutional investor activity and insider selling from EVP Irene Elizabeth Hudson and Shiela Vinczeller. Despite these sales, AptarGroup's financial outlook remains strong, with Q1 earnings and revenue exceeding expectations, a declared quarterly dividend, and analysts maintaining a "Moderate Buy" rating with a consensus price target of $173.25.
Insider Sell Alert: Shiela Vinczeller Sells Shares of AptarGroup Inc (ATR)
Shiela Vinczeller, Chief Human Resources Officer at AptarGroup Inc, sold 3,555 shares of the company on June 4, 2026, and now holds 27,078 shares. Over the past year, Vinczeller has sold 4,722 shares with no purchases, contributing to a total of 11 insider sells and no buys for AptarGroup Inc. The stock traded at $112.61, indicating it is modestly undervalued with a price-to-GF-Value ratio of 0.72.
Aptargroup CHRO Shiela Vinczeller sells $400,341 in company stock By Investing.com
Shiela Vinczeller, Chief Human Resources Officer at Aptargroup (NASDAQ:ATR), sold 3,555 shares of company stock on June 4, 2026, totaling $400,341. Following these transactions, Vinczeller still holds 27,078 shares. The sale comes as ATR stock trades near its 52-week low but is considered undervalued by InvestingPro, despite a 33-year streak of dividend increases, and follows a strong Q1 2026 earnings report and an increased price target from BofA Securities.
AptarGroup (NYSE:ATR) Insider Sells $400,328.55 in Stock
AptarGroup insider Shiela Vinczeller sold 3,555 shares of the company stock worth approximately $400,328.55 on June 4th, reducing her ownership by 11.61%. The company's stock rose 0.7% to $113.30, and it recently reported strong first-quarter earnings and revenue, beating analyst estimates. AptarGroup also authorized a $600 million stock buyback and paid a quarterly dividend of $0.48 per share, with analysts currently maintaining a "Moderate Buy" rating for the stock.
Aptargroup CHRO Shiela Vinczeller sells $400,341 in company stock
Shiela Vinczeller, CHRO of Aptargroup, sold 3,555 shares of company stock for over $400,000 on June 4, 2026. Following these transactions, she retains direct ownership of 27,078 shares. The sale comes as the stock trades near its 52-week low, despite recent positive financial results and an increased price target from BofA Securities.
